Neurogene Inc. (NGNE) vs Orthofix Medical Inc. (OFIX)

A side-by-side comparison of Neurogene Inc. and Orthofix Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NGNE vs OFIX

growth of $100 · dividends reinvested · last 10y
NGNE -90.2% (-20.8%/yr)OFIX -77.1% (-13.7%/yr)OFIX compounded faster over this window
050100150Start $10020182020202220242026$10$23
NGNE OFIX

NGNE vs OFIX: by the numbers

  • •NGNE is the larger company ($406M vs $385M market cap).
  • •Both run net losses; NGNE's is the smaller (0.00% vs -7.41% net margin).

Metrics side by side

Valuation

MetricNGNEOFIX
P/S ratioN/A0.46
P/B ratio1.870.90
EV / EBITDAN/A4.31

Profitability

MetricNGNEOFIX
Gross margin0.00%69.59%
Operating margin0.00%-3.05%
Net margin0.00%-7.41%
ROE-51.17%-14.38%
ROIC-54.45%-3.55%

Growth (annualized)

MetricNGNEOFIX
Revenue CAGR (5Y)N/A12.83%
Total return CAGR (5Y)-27.73%-23.97%

Frequently asked

How have NGNE and OFIX total returns compared?
Over the past 10 years, NGNE delivered -21.02% and OFIX delivered -13.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.